These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31592750)

  • 1. Precision Tumor Medicine and Drug Targets.
    Liu W; Wang X; Zhu H; Duan Y
    Curr Top Med Chem; 2019; 19(17):1488-1489. PubMed ID: 31592750
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial. Approaches to personalized medicine in oncology--the 9th Annual Meeting of CESAR in Greifswald.
    Ritter C; Sehrt D; Jaehde U
    Int J Clin Pharmacol Ther; 2012 Jan; 50(1):53-4. PubMed ID: 22192647
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene and drug matrix for personalized cancer therapy.
    Harris T
    Nat Rev Drug Discov; 2010 Aug; 9(8):660. PubMed ID: 20671766
    [No Abstract]   [Full Text] [Related]  

  • 4. Personalized medicine in oncology: the future is now.
    Schilsky RL
    Nat Rev Drug Discov; 2010 May; 9(5):363-6. PubMed ID: 20431568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision cancer medicine: where to target?
    Yu Q; Ding J
    Acta Pharmacol Sin; 2015 Oct; 36(10):1161-2. PubMed ID: 26388154
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial: Azoles in Anticancer Research: Rational Approaches, Design Strategies, Recent Insights and Future Perspectives.
    Gupta GK
    Anticancer Agents Med Chem; 2018; 18(1):4-5. PubMed ID: 29561251
    [No Abstract]   [Full Text] [Related]  

  • 7. Steps forward for cancer precision medicine.
    Salgado R; Moore H; Martens JWM; Lively T; Malik S; McDermott U; Michiels S; Moscow JA; Tejpar S; McKee T; Lacombe D;
    Nat Rev Drug Discov; 2018 Jan; 17(1):1-2. PubMed ID: 29170471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New ESMO scale ranks mutations as cancer medicine targets.
    Fricker J
    Lancet Oncol; 2018 Oct; 19(10):e513. PubMed ID: 30177495
    [No Abstract]   [Full Text] [Related]  

  • 9. Animal models for personalized treatment options.
    Fichtner I; Klinghammer K; Behrens D; Flechsig S; Rolff J; Becker M; Wulf-Goldenberg A; Stecklum M; Rivera M; Brzezicha B; Jandrig B; Hoffmann J
    Int J Clin Pharmacol Ther; 2017 Aug; 55(8):698-700. PubMed ID: 28696202
    [No Abstract]   [Full Text] [Related]  

  • 10. The p53 pathway: targets for the development of novel cancer therapeutics.
    Wang S; El-Deiry WS
    Cancer Treat Res; 2004; 119():175-87. PubMed ID: 15164878
    [No Abstract]   [Full Text] [Related]  

  • 11. Giving Up on Precision Oncology? Not So Fast!
    Warner JL
    Clin Transl Sci; 2017 May; 10(3):128-129. PubMed ID: 28146309
    [No Abstract]   [Full Text] [Related]  

  • 12. Weaponized antibodies use new tricks to fight cancer.
    Ledford H
    Nature; 2016 Nov; 540(7631):19-20. PubMed ID: 27905466
    [No Abstract]   [Full Text] [Related]  

  • 13. Inducing apoptosis: mind the natural killer cells.
    Gurwitz D; Gurwitz ML
    Drug Discov Today; 2003 Apr; 8(7):292. PubMed ID: 12654540
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial: Personalized cancer treatment.
    Tzelepi V
    Curr Mol Pharmacol; 2014; 7(1):2-3. PubMed ID: 25563850
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeting autophagy in antitumor agent design: furthering the 'lysosomal love' strategy.
    Sahni S; Kovacevic Z; Kalinowski DS; Huang M; Menezes S; Krishan S; Lane DJ; Jansson PJ; Richardson DR
    Future Med Chem; 2016 May; 8(7):727-9. PubMed ID: 27149429
    [No Abstract]   [Full Text] [Related]  

  • 16. Cancer-Related Systemic Inflammation: The Challenges and Therapeutic Opportunities for Personalized Medicine.
    Shinko D; Diakos CI; Clarke SJ; Charles KA
    Clin Pharmacol Ther; 2017 Oct; 102(4):599-610. PubMed ID: 28699186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA-Guided Precision Medicine for Cancer: A Case of Irrational Exuberance?
    Voest EE; Bernards R
    Cancer Discov; 2016 Feb; 6(2):130-2. PubMed ID: 26851184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of oncology therapeutics.
    Mansinho A; Boni V; de Miguel M; Calvo E
    Expert Rev Anticancer Ther; 2017 Jul; 17(7):563-565. PubMed ID: 28504011
    [No Abstract]   [Full Text] [Related]  

  • 19. Maurie Markman on the Groundbreaking TAPUR Trial.
    Markman M
    Oncology (Williston Park); 2017 Mar; 31(3):158, 168. PubMed ID: 28299751
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial: Targeting of Cancer Cells and Tumor Microenvironment: Perspectives for Personalized Therapy.
    Kzhyshkowska J; Bizzarri M; Apte R; Cherdyntseva N
    Curr Pharm Des; 2017; 23(32):4703-4704. PubMed ID: 29283049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.